Technical Analysis for CRTX - Cortexyme, Inc.

Grade Last Price % Change Price Change
F 32.87 1.61% 0.52
CRTX closed up 1.61 percent on Wednesday, February 24, 2021, on 76 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical CRTX trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Calm After Storm Range Contraction 1.61%
Wide Bands Range Expansion 1.61%
Oversold Stochastic Weakness 1.61%
MACD Bearish Centerline Cross Bearish 3.27%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 3.27%
Calm After Storm Range Contraction 3.27%
Older End-of-Day Signals for CRTX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout about 18 hours ago
Up 3% about 18 hours ago
Rose Above Previous Day's High about 19 hours ago
Up 2% about 19 hours ago
Up 1% about 19 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Cortexyme is a clinical stage pharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat a key underlying cause of Alzheimer's disease and other degenerative diseases. Cortexyme is targeting a specific, infectious pathogen found in the brain of Alzheimer’s patients and tied to neurodegeneration and neuroinflammation in animal models. The company's lead investigational medicine, COR388, is the subject of the GAIN Trial, an ongoing Phase 2/3 clinical study in patients with mild to moderate Alzheimer’s.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Organ Systems Inflammation Alzheimer's Disease Stage Pharmaceutical Degenerative Disease Mild Neurology Degenerative Diseases Neurodegeneration Nervous System

Is CRTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 58.99
52 Week Low 26.66
Average Volume 330,443
200-Day Moving Average 43.82
50-Day Moving Average 33.97
20-Day Moving Average 39.27
10-Day Moving Average 36.60
Average True Range 4.02
ADX 25.53
+DI 23.13
-DI 28.95
Chandelier Exit (Long, 3 ATRs ) 40.75
Chandelier Exit (Short, 3 ATRs ) 41.56
Upper Bollinger Band 52.24
Lower Bollinger Band 26.29
Percent B (%b) 0.25
BandWidth 66.10
MACD Line -0.96
MACD Signal Line 0.49
MACD Histogram -1.4529
Fundamentals Value
Market Cap 969.6 Million
Num Shares 29.5 Million
EPS -3.17
Price-to-Earnings (P/E) Ratio -10.37
Price-to-Sales 0.00
Price-to-Book 7.75
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 35.74
Resistance 3 (R3) 35.78 34.87 35.26
Resistance 2 (R2) 34.87 34.14 34.85 35.10
Resistance 1 (R1) 33.87 33.69 34.37 33.83 34.94
Pivot Point 32.96 32.96 33.21 32.94 32.96
Support 1 (S1) 31.96 32.23 32.46 31.92 30.80
Support 2 (S2) 31.05 31.78 31.03 30.64
Support 3 (S3) 30.05 31.05 30.48
Support 4 (S4) 30.01